SlideShare a Scribd company logo
FEVER IN INTENSIVE CARE
UNIT
Dr. Nathan Muluberhan(E M
r e s i d e n t )
August
2017
OUTLINE
 DEFINITIONS OF TERMS
 PATHOGENESIS OF FEVER
 SIGNIFICANCE OF FEVER
 FEVER IN ICU
 INFECTIOUS CAUSE
 NON INFECTIOUS CAUSE
DEFINITIONS
 F E V E R :
 elevation of body temperature that exceeds the normal daily
variation and occurs in conjunction with an increase in the hypothalamic set point.
 H Y P E R T H E R M I A :
 elevation of body temperature in a setting of unchanged the hypothalamic
thermoregulatory center is
 HYPERPYREXIA:
 an extraordinarily high fever (>41.5ºC)
 P Y R O G E N S :
 is any substance that causes fever
PATHOGENESIS
TEMPERATURE MEASUREMENT
 Normal body temperature is generally considered to be
37.0°C (98.6°F) with a circadian variation of between 0.5
to 1.0°C.
 The Society of Critical Care Medicine define fever in the
ICU as a temperature >38.3°C (>101°F).
SIGNIFICANCE OF FEVER
 Enhance the resistance of animals to infection
 Enhance several parameters of immune
function
 some pathogens such as Streptococcus
pneumoniae are inhibited by febrile
temperatures.
 a To of 38°C shown to increased survival in
patients with SBP
 Increase
 cardiac output
 oxygen consumption
 carbon dioxide production
 energy expenditure
 Poor neurologic outcome in patients with stroke and TBI.
 Maternal fever has been suggested to be a cause
 fetal malformations and spontaneous abortions
SIGNIFICANCE OF FEVER CONT…
FEVER IN ICU
 Fever complicates up to 70 % of all ICU admissions.
 DIFFERENTIAL:
 Fevers between 38.3ºC (101ºF) and 38.8ºC (101.8ºF) may be
infectious or noninfectious.
 Fevers between 38.9 (102ºF) and 41ºC (105.8ºF) can be
assumed to be infectious.
 Fevers ≥41.1ºC (106ºF) are usually noninfectious.
INFECTIOUS CAUSES OF FEVER
 Bacteremia
 VAP
 Intravascular
catheter-related
infection
 Surgical site
infection
 Sinusitis
 Cellulitis
 Cholangitis
 Diverticulitis
 Empyema
 Intra-abdominal
abscess
 Endocarditis
 Myonecrosis
 Necrotizing
fasciitis
 Pseudomembran
oucolitis
 Septic arthritis
VENTILATOR-ASSOCIATED PNEUMONIA(VAP)
 Incidence of 10 -25%
 Attributable mortality of 25-50 %
 Risk of 3%/day the first five days, 2%/day during
day 5 to 10 and 1%/day the day after that.
 Typically presents with:
 a new or progressive pulmonary infiltrate
 one or more of the following findings:
 fever, purulent tracheobronchial secretions,
leukocytosis,
 increased respiratory rate, decreased tidal
volume, increased minute ventilation, and
decreased oxygenation
VENTILATOR-ASSOCIATED PNEUMONIA
CONT…
CATHETER-ASSOCIATED SEPSIS
 is defined as blood stream infection due to an organism
that has colonized a vascular catheter
 Approximately 5% of patients with indwelling vascular
catheters (uncoated) will develop blood stream infection
 If catheter sepsis is suspected
 the catheter should be changed to a new site
 Send culture of the catheter tip.
CATHETER-ASSOCIATED SEPSIS
CONT…
URINARY TRACT INFECTIONS (UTIS)
 account for between 25 to 50% of all infections
 Defined as:
 the presence of fever >38ºC, SPT, CVAT
 Urine culture with
 >10(5) cfu/mL irrespective of urinalysis
 >10(3) cfu/mL with evidence of pyuria
 Bacteriuria should be treated following
 urinary tract manipulation or surgery
 patients with kidney stones & urinary tract
obstruction
 Patient with neutropenia
URINARY TRACT INFECTIONS CONT…
CLOSTRIDIA DIFFICILE Colitis
 About 20% of all hospitalized patients become
“infected” with C difficile
 only 1/3 develop diarrhea.
 Use of clindamycin, 3rd generation cephalosporin
and fluoroquinolones is the risk factor
 Other risk factors:
 use of PPI, GI surgery, prolonged ICU stay and tube
feeding
 Symptoms usually begins shortly after
antibiotics therapy
 Clinical spectrum includes:
 Colitis, pseudomembranous colitis, fulminant
colitis
 Stool assay for toxin A and B by ELISA
 Further work up: cytotoxic assay,
sigmoidoscopy and CT scan
CLOSTRIDIA DIFFICILE Colitis
CONT…
 Stop the offending antibiotics if possible
 Provide adequate fluid and electrolytes
 Don’t use antimotility agents
 If specific rx required use metronidazole
 Strict contact isolation of the patient
CLOSTRIDIA DIFFICILE Colitis
CONT…
SINUSITIS
 sinusitis is common following nasal
intubation
 with an incidence of up to 85% after a week of
intubation.
 The maxillary sinus is most commonly
involved
 Major criteria: cough & purulent nasal discharge
 Minor criteria: headache or earache, facial or tooth
pain, fever, malodours breath sore throat and
wheezing
 Sinusitis on CT
 total opacification
 the presence of an air fluid level within any of the
paranasal sinuses.
SINUSITIS CONT…
 MICROBIOLOGY:
 Pseudomonas (60%)
 Stap. Aureus (33%)
 Treatment
 Remove all nasal tubes
 Drainage (Needle(Maxillary) or surgical (ethmoid and
sphenoid))
 Antibiotics
SINUSITIS CONT…
Brain Cerebral infraction/ hemorrhage, SAH
Heart MI, Pericarditis
Pulmonary Aspiration, Atelectasis, PE, ARDS
Abdomen GI bleeding, ischemic bowel, pancreatitis, hepatitis, adrenal
crisis
vascular DVT, Thrombophlebitis
cutaneous Decubitus ulcers
miscellaneou Drug fever, fat embolism, neoplasms, blood transfusion, gout,
NON INFECTIOUS CAUSES OF FEVER
DRUG FEVER
 It can occur several days after the initiation of the
drug,
 can produce high fevers (>38.9ºC) without other
signs.
 The true incidence is unknown.
 Cause:
 Stimulation of heat production(eg. Thyroxine)
 Limit of heat dissipation (eg. atropine)
 Alter thermoregultion (eg. antihistamines,
ADRENAL CRISIS
 occurs in patients with previously adrenal
insufficiency who are subjected to a serious
infection or other major stress.
 manifestation
 Distributive shock is the predominant
 fever, nausea, vomiting, abdominal pain, fatigue,
lethargy, hypoglycemia, confusion, or coma
EMERGENCY TREATMENT
 Adequate fluid resuscitation
 Draw blood for electrolytes, glucose, cortisol and
ACTH
 Glucocorticoid
 Dexamethasone
 Hydrocortisone is preferred with known primary
adrenal insufficiency with potassium >6.0 meq/L.
(because of its mineralocorticoid activity)
ADRENAL CRISIS CONT…
ACUTE HEMOLYTIC TRANSFUSION
REACTION
 A medical emergency that results from the
rapid destruction of donor red blood cells by
recipient antibodies.
 Usually due to ABO incompatibility.
 Common clinical manifestations
 fever, chills, distributive shock, disseminated
intravascular coagulation, and acute kidney injury.
 Stop the transfusion.
 Maintain the patient's airway, blood pressure, and
heart rate.
 Begin an infusion of normal saline immediately
 Avoid the use of Ringer's lactate solution because its
content of calcium may initiate clotting of any blood
remaining in the intravenous line.
 Avoid dextrose- containing solutions because the dextrose
may hemolyze any of the remaining red cells in the line.
ACUTE HEMOLYTIC TRANSFUSION
REACTION CONT…
ACALCULOUS CHOLECYSTITIS
 0.2 to 1.5 % of patients in ICU
 presents with fever, leukocytosis, and vague
abdominal discomfort.
 May progress to gangrene and perforation.
 have a mortality rate as high as 30 to 40 %
 ULTRASOUND
 Absence of gallstones or sludge
 Thickening of the gallbladder wall (>5 mm) with pericholecystic
fluid
 A positive Murphy's sign induced by the ultrasound probe
 Failure to visualize the gallbladder
 Frank perforation of the gallbladder with associated abscess
formation
 TREATMENT
 broad spectrum antibiotics
 cholecystectomy with drainage of any associated abscess
ACALCULOUS CHOLECYSTITIS
CONT…
ANTIBIOTIC USE IN INTENSIVE
CARE UNIT
Dr. Nathan Muluberhan(E M
r e s i d e n t )
August 2017
OBJECTIVES
 principles of antibiotic use
 optimize use of antibiotic
 multidrug resistant bacteria
 To look at the role of novel biomarker
in guiding antibiotic therapy
PRINCIPLES OF ANTIBIOTIC
PRESCRIPTION
 Send for appropriate investigations (minimum required
for dx, prognosis and follow up) before initiation of
antibiotics
 Change in antibiotics would be done after sending fresh
culture
 Follow the hospital antibiotics policy. If alternative has
chosen, document the reason
 Check for factors which will affects drug choice and
dose(eg. Renal function, interaction and allergy)
 Check appropriate dose is prescribed
 All IV antibiotics may only given for 48-72 hrs without
review
 Once culture result available descalate and if not,
document the reason
 Emperic therapy initation delay for await of micro report
would be life threatining and mortality rate will be
increased
 Antibiotics therapy based on a clinically defined infection
is justified
 Rapid tests such as gram stain can help determine
theraputic choice when emperic therapy is required
PRINCIPLES OF ANTIBIOTIC
PRESCRIPTION
STRATEGIES TO OPTIMIZE THE USE
OF ANTIMICROBIALS
1. Use of PK/PD parameters for dose
adjustment
2. De-escalation therapy
3. Antibacterial cycling
4. Pre-emptive therapy
YUMC
1. CONCENTRATION DEPENDENT KILLING ACTIVITY
AND MODERATE TO PROLONGED PERSISTENT
EFFECTS
 More rapid killing effect against micro organisms than
low concentrations
 Allows the administrations of high doses with widely
separated frequencies of administration
 Aminoglycosides, Fluoroquinolones, Metronidazole,
Colistin, Rifampicin, Clindamycin
CONCENTRATION DEPENDENT CONT…
 AMINOGLYCOSIDES
 Doses of these antimicrobials administered to critically ill patients
are frequently insufficient
Rea RS, et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther
Drug Monit 2008; 30: 674-81
 FLUOROQUINOLONES
 Using a Monte Carlo dosing simulation, doses of 400mg every 8-
12hrs givento 1-2 patients did not reach the necessary killing
concentrations for P.aeruginosa, A.baumannii strains
2. TIME DEPENDENT KILLING ACTIVITY AND
MINIMAL PERSISTENT EFFECTS
 Maintain blood concentrations above MIC for
prolonged time periods
 These drugs should be given by continuous
infusion
 Beta lactams and Linezolid
3. TIME DEPENDENT KILLING ACTIVITY AND
MODERATE TO PROLONGED PERSISTENT EFFECTS
 Glycopeptides (Vancomycin, Teicoplanin)
 The duration of effect is longer and the possibility of
regrowth of micro-organisms during the dosing
interval is more limited
 In humans, AUC/MIC value >350 was an independent
factor associated with clinical success in patients with
S.aureus proven lower respiratory tract infection
 Tetracyclines
DE-ESCALATION THERAPY
 Initial administration of broad spectrum empirical
treatment
 To cover pathogens, most frequently related to the
infection
 Rapid adjustment of antibacterial treatment
once the causative pathogen has been identified
STARTING ANTIBIOTIC THERAPY
DURATION OF ANTIBIOTIC THERAPY
 The optimal duration of antibiotic therapy for
bacteremia is unknown.
 some evidence that would suggest that there
is no significant difference in mortality, clinical
and microbiological cure b/n shorter and long
durations
 i.e. 5 – 7 days versus 8 -21 days in critically ill
patients with bacteremia.
ANTIBACTERIAL CYCLING
 The scheduled rotation of one class of
antibacterial
 One or more different classes with comparable
spectra of activity
 Different mechanisms of resistance
 Some weeks and a few months
PRE-EMPTIVE THERAPY
 The administration of antimicrobials in certain
patients at very high risk of opportunistic infections
before the onset of clinical signs of infection
 Developed in hematological patients and/or transplant
recipients
 CMV, aspergillosis
 In critical illness patients at high risk of candidemia or
invasive candidiasis
CANDIDA SCORE
 A bedside scoring system for preemptive antifungal
treatment in nonneutropenic critically ill patients with
Candida colonization. Crit Care Med 2006; 34: 730-7
 “Candida score” >2.5 accurately selected patients who
would benefit from early antifungal treatment.
Candida score = 0.908* (TPN) + 0.997* (surgery)+ 1.112* (multifocal candida
colonization) + 2.038* (severe sepsis)
1 if present
0 if absent
MULTIDRUG RESISTANT
BACTERIA
 Increasing prevalence of multidrug-resistant
pathogens in ICUs
 CDC Report shows from 1999 and 2006/2007
 VRE (from 24.7% to 33.3 % of enterococci isolates)
 MRSA (from 53.5 % to 56.2 % of S. aureus isolates)
 P. aeruginosa resistant to imipenem (from16.4 to
25.3) or fluoroquinolones (from 23.0 to 30.7) from P.
aeruginosa isolates
RISK FACTORS
 Older age
 Presence of underlying comorbid conditions
 higher severity of illness indices
 Long hospital courses prior to the ICU admission,
 Receipt of antimicrobial therapy prior to the ICU
admission.
 Presence of indwelling devices
 Recent surgery or other invasive procedure
 Frequent manipulation and contact with healthcare
person
PREVENTION OF RESISTANCE IN THE ICU
 Strategies can be separated into two major
categories:
 strategies that attempt to improve the efficacy and
utilization of antimicrobial therapy
 infection control measures
INFECTION CONTROL MEASURES
 good hand hygiene compliance
 Active surveillance of patients for
asymptomatic colonization
 Institution surveillance for infections with
multidrug-resistant bacteria
 Daily chlorhexidine bathing
NOVEL BIOMARKERS
 PROCALCITONIN
 best studied biomarker for guiding antibiotic treatment
duration in the hospital setting.
 It’s dynamics within 72 hours after onset of sepsis may be
correlated both with appropriateness of the empirical
antibiotic therapy
 integrated in clinical algorithms have been shown to
reduce the duration of antibiotic courses by 25-65% in
hospitalized and more severely ill patients with CAP and
sepsis
REFERENCES
 Harrison's Principles of Internal Medicine, 19th ed
 Up-to-date 21.6
 Practice Guidelines for Evaluating New Fever in
Critically Ill Adult Patients. From the National Institutes
of Health, Bethesda, and the Johns Hopkins Hospital and St.
Agnes Hospital
 Annual Update in Intensive Care and Emergency
Medicine 2016
Thank You

More Related Content

What's hot

Recent guidelines in antibiotics uses
Recent guidelines in antibiotics usesRecent guidelines in antibiotics uses
Recent guidelines in antibiotics uses
Shivshankar Badole
 
Pneumonia
Pneumonia Pneumonia
Pneumonia
HariomSuman
 
Antimicrobial stewardship
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardship
Mohd Saif Khan
 
Rational use of antimicrobials
Rational use of antimicrobialsRational use of antimicrobials
Rational use of antimicrobials
Rajat Biswas
 
Lower respiratory tract infection Pneumonia
Lower respiratory tract infection PneumoniaLower respiratory tract infection Pneumonia
Lower respiratory tract infection Pneumonia
Fadzlina Zabri
 
Managing MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICUManaging MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICU
Vitrag Shah
 
Respiratory tract infections
Respiratory tract infectionsRespiratory tract infections
Respiratory tract infections
velspharmd
 
Management Of Community Acquired Pneumonia
Management  Of Community Acquired PneumoniaManagement  Of Community Acquired Pneumonia
Management Of Community Acquired Pneumonia
Ashraf ElAdawy
 
8 Lower Respiratory Infections
8 Lower Respiratory Infections8 Lower Respiratory Infections
8 Lower Respiratory Infections
Yaser Ammar
 
principles of antibiotic use in critical care
principles of antibiotic use in critical careprinciples of antibiotic use in critical care
principles of antibiotic use in critical care
Ahmed Abdelazeem
 
Pharmacodynamics of antibiotics
Pharmacodynamics of antibioticsPharmacodynamics of antibiotics
Pharmacodynamics of antibiotics
Htet Wai Moe
 
Varicella zoster virus
Varicella zoster virusVaricella zoster virus
Varicella zoster virus
Kaveh Haratian
 
Community acquired pneumonia
Community acquired pneumoniaCommunity acquired pneumonia
Community acquired pneumonia
Zia Hashim
 
Pneumonia - Community Acquired Pneumonia (CAP)
Pneumonia  - Community Acquired Pneumonia (CAP)Pneumonia  - Community Acquired Pneumonia (CAP)
Pneumonia - Community Acquired Pneumonia (CAP)
Arshia Nozari
 
Croup
CroupCroup
Croup
Pediatrics
 
Rational use of antibiotics & problem of antibiotic resistense
Rational use of antibiotics & problem of antibiotic resistenseRational use of antibiotics & problem of antibiotic resistense
Rational use of antibiotics & problem of antibiotic resistense
Virendra Hindustani
 
Management of community acquired pneumonia
Management of community acquired pneumoniaManagement of community acquired pneumonia
Management of community acquired pneumoniaNahid Sherbini
 

What's hot (20)

Recent guidelines in antibiotics uses
Recent guidelines in antibiotics usesRecent guidelines in antibiotics uses
Recent guidelines in antibiotics uses
 
Pneumonia
Pneumonia Pneumonia
Pneumonia
 
Antimicrobial stewardship
Antimicrobial stewardshipAntimicrobial stewardship
Antimicrobial stewardship
 
Rational use of antimicrobials
Rational use of antimicrobialsRational use of antimicrobials
Rational use of antimicrobials
 
Lower respiratory tract infection Pneumonia
Lower respiratory tract infection PneumoniaLower respiratory tract infection Pneumonia
Lower respiratory tract infection Pneumonia
 
Managing MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICUManaging MDR/XDR Gram Negative infections in ICU
Managing MDR/XDR Gram Negative infections in ICU
 
Respiratory tract infections
Respiratory tract infectionsRespiratory tract infections
Respiratory tract infections
 
Management Of Community Acquired Pneumonia
Management  Of Community Acquired PneumoniaManagement  Of Community Acquired Pneumonia
Management Of Community Acquired Pneumonia
 
8 Lower Respiratory Infections
8 Lower Respiratory Infections8 Lower Respiratory Infections
8 Lower Respiratory Infections
 
principles of antibiotic use in critical care
principles of antibiotic use in critical careprinciples of antibiotic use in critical care
principles of antibiotic use in critical care
 
Pharmacodynamics of antibiotics
Pharmacodynamics of antibioticsPharmacodynamics of antibiotics
Pharmacodynamics of antibiotics
 
Tuberculosis
Tuberculosis Tuberculosis
Tuberculosis
 
Varicella zoster virus
Varicella zoster virusVaricella zoster virus
Varicella zoster virus
 
Community acquired pneumonia
Community acquired pneumoniaCommunity acquired pneumonia
Community acquired pneumonia
 
Pneumonia - Community Acquired Pneumonia (CAP)
Pneumonia  - Community Acquired Pneumonia (CAP)Pneumonia  - Community Acquired Pneumonia (CAP)
Pneumonia - Community Acquired Pneumonia (CAP)
 
Croup
CroupCroup
Croup
 
Rational use of antibiotics & problem of antibiotic resistense
Rational use of antibiotics & problem of antibiotic resistenseRational use of antibiotics & problem of antibiotic resistense
Rational use of antibiotics & problem of antibiotic resistense
 
Management of community acquired pneumonia
Management of community acquired pneumoniaManagement of community acquired pneumonia
Management of community acquired pneumonia
 
Pulmonary Tuberculosis
Pulmonary TuberculosisPulmonary Tuberculosis
Pulmonary Tuberculosis
 
Mrsa
MrsaMrsa
Mrsa
 

Similar to Fever and antibiotics

FN, sepsis and shock
FN, sepsis and shockFN, sepsis and shock
FN, sepsis and shockderosaMSKCC
 
Gram Negative Sepsis
Gram Negative SepsisGram Negative Sepsis
Gram Negative Sepsis
shabeel pn
 
Anaesthesia for septic patient
Anaesthesia for septic patientAnaesthesia for septic patient
Anaesthesia for septic patientArun Gupta
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndrome
Amit Badgal
 
FEBRILE NEUTROPAENIA IN PAEDIATRICS
 FEBRILE NEUTROPAENIA IN PAEDIATRICS FEBRILE NEUTROPAENIA IN PAEDIATRICS
FEBRILE NEUTROPAENIA IN PAEDIATRICS
AgabaAdoyi
 
Community- Acquired Pneumonia
Community- Acquired PneumoniaCommunity- Acquired Pneumonia
Community- Acquired Pneumonia
Sun Yai-Cheng
 
Fever in icu pptx
Fever in icu pptxFever in icu pptx
Fever in icu pptx
Prasant N
 
Sepsis 2009 update final
Sepsis 2009 update finalSepsis 2009 update final
Sepsis 2009 update final
Troy Pennington
 
Sepsis in Pregnancy
Sepsis in PregnancySepsis in Pregnancy
Sepsis in Pregnancy
Kervindran Mohanasundaram
 
Septic shock.pptx
Septic shock.pptxSeptic shock.pptx
Septic shock.pptx
OdjugoEretare
 
Septic shock management (1)
Septic shock management (1)Septic shock management (1)
Septic shock management (1)
shashank agrawal
 
Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015Matthew Rosenfeld, PharmD
 
infective endocarditis a complete presentation.ppt
infective endocarditis a complete presentation.pptinfective endocarditis a complete presentation.ppt
infective endocarditis a complete presentation.ppt
tejasnangalia07
 
Anaphylaxis and septicemia
Anaphylaxis and septicemiaAnaphylaxis and septicemia
Anaphylaxis and septicemia
THANUJA MATHEW
 
Update management of CAP
Update management of CAPUpdate management of CAP
Update management of CAP
Saher Farghly
 
fever in the postoperative period .ppt
fever in the postoperative period .pptfever in the postoperative period .ppt
fever in the postoperative period .ppt
SinzianaIonescu1
 

Similar to Fever and antibiotics (20)

FEVER IN ICU
FEVER IN ICUFEVER IN ICU
FEVER IN ICU
 
FN, sepsis and shock
FN, sepsis and shockFN, sepsis and shock
FN, sepsis and shock
 
Sepsis
SepsisSepsis
Sepsis
 
Gram Negative Sepsis
Gram Negative SepsisGram Negative Sepsis
Gram Negative Sepsis
 
Anaesthesia for septic patient
Anaesthesia for septic patientAnaesthesia for septic patient
Anaesthesia for septic patient
 
Sepesis lecture
Sepesis lectureSepesis lecture
Sepesis lecture
 
Acute respiratory distress syndrome
Acute respiratory distress syndromeAcute respiratory distress syndrome
Acute respiratory distress syndrome
 
FEBRILE NEUTROPAENIA IN PAEDIATRICS
 FEBRILE NEUTROPAENIA IN PAEDIATRICS FEBRILE NEUTROPAENIA IN PAEDIATRICS
FEBRILE NEUTROPAENIA IN PAEDIATRICS
 
Community- Acquired Pneumonia
Community- Acquired PneumoniaCommunity- Acquired Pneumonia
Community- Acquired Pneumonia
 
Bundle of sepsis
Bundle of sepsisBundle of sepsis
Bundle of sepsis
 
Fever in icu pptx
Fever in icu pptxFever in icu pptx
Fever in icu pptx
 
Sepsis 2009 update final
Sepsis 2009 update finalSepsis 2009 update final
Sepsis 2009 update final
 
Sepsis in Pregnancy
Sepsis in PregnancySepsis in Pregnancy
Sepsis in Pregnancy
 
Septic shock.pptx
Septic shock.pptxSeptic shock.pptx
Septic shock.pptx
 
Septic shock management (1)
Septic shock management (1)Septic shock management (1)
Septic shock management (1)
 
Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015
 
infective endocarditis a complete presentation.ppt
infective endocarditis a complete presentation.pptinfective endocarditis a complete presentation.ppt
infective endocarditis a complete presentation.ppt
 
Anaphylaxis and septicemia
Anaphylaxis and septicemiaAnaphylaxis and septicemia
Anaphylaxis and septicemia
 
Update management of CAP
Update management of CAPUpdate management of CAP
Update management of CAP
 
fever in the postoperative period .ppt
fever in the postoperative period .pptfever in the postoperative period .ppt
fever in the postoperative period .ppt
 

Recently uploaded

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Dr Jeenal Mistry
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
greendigital
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
Anujkumaranit
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
GL Anaacs
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
Shweta
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
rebeccabio
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Savita Shen $i11
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
jval Landero
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
DR SETH JOTHAM
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
Anurag Sharma
 

Recently uploaded (20)

Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdfAlcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
Alcohol_Dr. Jeenal Mistry MD Pharmacology.pdf
 
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness JourneyTom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journey
 
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdfARTIFICIAL INTELLIGENCE IN  HEALTHCARE.pdf
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdf
 
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...
 
Evaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animalsEvaluation of antidepressant activity of clitoris ternatea in animals
Evaluation of antidepressant activity of clitoris ternatea in animals
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in StockFactory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
Factory Supply Best Quality Pmk Oil CAS 28578–16–7 PMK Powder in Stock
 
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
Phone Us ❤85270-49040❤ #ℂall #gIRLS In Surat By Surat @ℂall @Girls Hotel With...
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Surgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptxSurgical Site Infections, pathophysiology, and prevention.pptx
Surgical Site Infections, pathophysiology, and prevention.pptx
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdfBENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
BENIGN PROSTATIC HYPERPLASIA.BPH. BPHpdf
 
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptxTriangles of Neck and Clinical Correlation by Dr. RIG.pptx
Triangles of Neck and Clinical Correlation by Dr. RIG.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
micro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdfmicro teaching on communication m.sc nursing.pdf
micro teaching on communication m.sc nursing.pdf
 

Fever and antibiotics

  • 1. FEVER IN INTENSIVE CARE UNIT Dr. Nathan Muluberhan(E M r e s i d e n t ) August 2017
  • 2. OUTLINE  DEFINITIONS OF TERMS  PATHOGENESIS OF FEVER  SIGNIFICANCE OF FEVER  FEVER IN ICU  INFECTIOUS CAUSE  NON INFECTIOUS CAUSE
  • 3. DEFINITIONS  F E V E R :  elevation of body temperature that exceeds the normal daily variation and occurs in conjunction with an increase in the hypothalamic set point.  H Y P E R T H E R M I A :  elevation of body temperature in a setting of unchanged the hypothalamic thermoregulatory center is  HYPERPYREXIA:  an extraordinarily high fever (>41.5ºC)  P Y R O G E N S :  is any substance that causes fever
  • 5. TEMPERATURE MEASUREMENT  Normal body temperature is generally considered to be 37.0°C (98.6°F) with a circadian variation of between 0.5 to 1.0°C.  The Society of Critical Care Medicine define fever in the ICU as a temperature >38.3°C (>101°F).
  • 6. SIGNIFICANCE OF FEVER  Enhance the resistance of animals to infection  Enhance several parameters of immune function  some pathogens such as Streptococcus pneumoniae are inhibited by febrile temperatures.  a To of 38°C shown to increased survival in patients with SBP
  • 7.  Increase  cardiac output  oxygen consumption  carbon dioxide production  energy expenditure  Poor neurologic outcome in patients with stroke and TBI.  Maternal fever has been suggested to be a cause  fetal malformations and spontaneous abortions SIGNIFICANCE OF FEVER CONT…
  • 8. FEVER IN ICU  Fever complicates up to 70 % of all ICU admissions.  DIFFERENTIAL:  Fevers between 38.3ºC (101ºF) and 38.8ºC (101.8ºF) may be infectious or noninfectious.  Fevers between 38.9 (102ºF) and 41ºC (105.8ºF) can be assumed to be infectious.  Fevers ≥41.1ºC (106ºF) are usually noninfectious.
  • 9. INFECTIOUS CAUSES OF FEVER  Bacteremia  VAP  Intravascular catheter-related infection  Surgical site infection  Sinusitis  Cellulitis  Cholangitis  Diverticulitis  Empyema  Intra-abdominal abscess  Endocarditis  Myonecrosis  Necrotizing fasciitis  Pseudomembran oucolitis  Septic arthritis
  • 10. VENTILATOR-ASSOCIATED PNEUMONIA(VAP)  Incidence of 10 -25%  Attributable mortality of 25-50 %  Risk of 3%/day the first five days, 2%/day during day 5 to 10 and 1%/day the day after that.
  • 11.  Typically presents with:  a new or progressive pulmonary infiltrate  one or more of the following findings:  fever, purulent tracheobronchial secretions, leukocytosis,  increased respiratory rate, decreased tidal volume, increased minute ventilation, and decreased oxygenation VENTILATOR-ASSOCIATED PNEUMONIA CONT…
  • 12. CATHETER-ASSOCIATED SEPSIS  is defined as blood stream infection due to an organism that has colonized a vascular catheter  Approximately 5% of patients with indwelling vascular catheters (uncoated) will develop blood stream infection
  • 13.  If catheter sepsis is suspected  the catheter should be changed to a new site  Send culture of the catheter tip. CATHETER-ASSOCIATED SEPSIS CONT…
  • 14. URINARY TRACT INFECTIONS (UTIS)  account for between 25 to 50% of all infections  Defined as:  the presence of fever >38ºC, SPT, CVAT  Urine culture with  >10(5) cfu/mL irrespective of urinalysis  >10(3) cfu/mL with evidence of pyuria
  • 15.  Bacteriuria should be treated following  urinary tract manipulation or surgery  patients with kidney stones & urinary tract obstruction  Patient with neutropenia URINARY TRACT INFECTIONS CONT…
  • 16. CLOSTRIDIA DIFFICILE Colitis  About 20% of all hospitalized patients become “infected” with C difficile  only 1/3 develop diarrhea.  Use of clindamycin, 3rd generation cephalosporin and fluoroquinolones is the risk factor  Other risk factors:  use of PPI, GI surgery, prolonged ICU stay and tube feeding
  • 17.  Symptoms usually begins shortly after antibiotics therapy  Clinical spectrum includes:  Colitis, pseudomembranous colitis, fulminant colitis  Stool assay for toxin A and B by ELISA  Further work up: cytotoxic assay, sigmoidoscopy and CT scan CLOSTRIDIA DIFFICILE Colitis CONT…
  • 18.  Stop the offending antibiotics if possible  Provide adequate fluid and electrolytes  Don’t use antimotility agents  If specific rx required use metronidazole  Strict contact isolation of the patient CLOSTRIDIA DIFFICILE Colitis CONT…
  • 19. SINUSITIS  sinusitis is common following nasal intubation  with an incidence of up to 85% after a week of intubation.  The maxillary sinus is most commonly involved
  • 20.  Major criteria: cough & purulent nasal discharge  Minor criteria: headache or earache, facial or tooth pain, fever, malodours breath sore throat and wheezing  Sinusitis on CT  total opacification  the presence of an air fluid level within any of the paranasal sinuses. SINUSITIS CONT…
  • 21.  MICROBIOLOGY:  Pseudomonas (60%)  Stap. Aureus (33%)  Treatment  Remove all nasal tubes  Drainage (Needle(Maxillary) or surgical (ethmoid and sphenoid))  Antibiotics SINUSITIS CONT…
  • 22. Brain Cerebral infraction/ hemorrhage, SAH Heart MI, Pericarditis Pulmonary Aspiration, Atelectasis, PE, ARDS Abdomen GI bleeding, ischemic bowel, pancreatitis, hepatitis, adrenal crisis vascular DVT, Thrombophlebitis cutaneous Decubitus ulcers miscellaneou Drug fever, fat embolism, neoplasms, blood transfusion, gout, NON INFECTIOUS CAUSES OF FEVER
  • 23. DRUG FEVER  It can occur several days after the initiation of the drug,  can produce high fevers (>38.9ºC) without other signs.  The true incidence is unknown.  Cause:  Stimulation of heat production(eg. Thyroxine)  Limit of heat dissipation (eg. atropine)  Alter thermoregultion (eg. antihistamines,
  • 24. ADRENAL CRISIS  occurs in patients with previously adrenal insufficiency who are subjected to a serious infection or other major stress.  manifestation  Distributive shock is the predominant  fever, nausea, vomiting, abdominal pain, fatigue, lethargy, hypoglycemia, confusion, or coma
  • 25. EMERGENCY TREATMENT  Adequate fluid resuscitation  Draw blood for electrolytes, glucose, cortisol and ACTH  Glucocorticoid  Dexamethasone  Hydrocortisone is preferred with known primary adrenal insufficiency with potassium >6.0 meq/L. (because of its mineralocorticoid activity) ADRENAL CRISIS CONT…
  • 26. ACUTE HEMOLYTIC TRANSFUSION REACTION  A medical emergency that results from the rapid destruction of donor red blood cells by recipient antibodies.  Usually due to ABO incompatibility.  Common clinical manifestations  fever, chills, distributive shock, disseminated intravascular coagulation, and acute kidney injury.
  • 27.  Stop the transfusion.  Maintain the patient's airway, blood pressure, and heart rate.  Begin an infusion of normal saline immediately  Avoid the use of Ringer's lactate solution because its content of calcium may initiate clotting of any blood remaining in the intravenous line.  Avoid dextrose- containing solutions because the dextrose may hemolyze any of the remaining red cells in the line. ACUTE HEMOLYTIC TRANSFUSION REACTION CONT…
  • 28. ACALCULOUS CHOLECYSTITIS  0.2 to 1.5 % of patients in ICU  presents with fever, leukocytosis, and vague abdominal discomfort.  May progress to gangrene and perforation.  have a mortality rate as high as 30 to 40 %
  • 29.  ULTRASOUND  Absence of gallstones or sludge  Thickening of the gallbladder wall (>5 mm) with pericholecystic fluid  A positive Murphy's sign induced by the ultrasound probe  Failure to visualize the gallbladder  Frank perforation of the gallbladder with associated abscess formation  TREATMENT  broad spectrum antibiotics  cholecystectomy with drainage of any associated abscess ACALCULOUS CHOLECYSTITIS CONT…
  • 30. ANTIBIOTIC USE IN INTENSIVE CARE UNIT Dr. Nathan Muluberhan(E M r e s i d e n t ) August 2017
  • 31. OBJECTIVES  principles of antibiotic use  optimize use of antibiotic  multidrug resistant bacteria  To look at the role of novel biomarker in guiding antibiotic therapy
  • 32. PRINCIPLES OF ANTIBIOTIC PRESCRIPTION  Send for appropriate investigations (minimum required for dx, prognosis and follow up) before initiation of antibiotics  Change in antibiotics would be done after sending fresh culture  Follow the hospital antibiotics policy. If alternative has chosen, document the reason  Check for factors which will affects drug choice and dose(eg. Renal function, interaction and allergy)  Check appropriate dose is prescribed
  • 33.  All IV antibiotics may only given for 48-72 hrs without review  Once culture result available descalate and if not, document the reason  Emperic therapy initation delay for await of micro report would be life threatining and mortality rate will be increased  Antibiotics therapy based on a clinically defined infection is justified  Rapid tests such as gram stain can help determine theraputic choice when emperic therapy is required PRINCIPLES OF ANTIBIOTIC PRESCRIPTION
  • 34. STRATEGIES TO OPTIMIZE THE USE OF ANTIMICROBIALS 1. Use of PK/PD parameters for dose adjustment 2. De-escalation therapy 3. Antibacterial cycling 4. Pre-emptive therapy
  • 35.
  • 36. YUMC
  • 37. 1. CONCENTRATION DEPENDENT KILLING ACTIVITY AND MODERATE TO PROLONGED PERSISTENT EFFECTS  More rapid killing effect against micro organisms than low concentrations  Allows the administrations of high doses with widely separated frequencies of administration  Aminoglycosides, Fluoroquinolones, Metronidazole, Colistin, Rifampicin, Clindamycin
  • 38. CONCENTRATION DEPENDENT CONT…  AMINOGLYCOSIDES  Doses of these antimicrobials administered to critically ill patients are frequently insufficient Rea RS, et al. Suboptimal aminoglycoside dosing in critically ill patients. Ther Drug Monit 2008; 30: 674-81  FLUOROQUINOLONES  Using a Monte Carlo dosing simulation, doses of 400mg every 8- 12hrs givento 1-2 patients did not reach the necessary killing concentrations for P.aeruginosa, A.baumannii strains
  • 39. 2. TIME DEPENDENT KILLING ACTIVITY AND MINIMAL PERSISTENT EFFECTS  Maintain blood concentrations above MIC for prolonged time periods  These drugs should be given by continuous infusion  Beta lactams and Linezolid
  • 40. 3. TIME DEPENDENT KILLING ACTIVITY AND MODERATE TO PROLONGED PERSISTENT EFFECTS  Glycopeptides (Vancomycin, Teicoplanin)  The duration of effect is longer and the possibility of regrowth of micro-organisms during the dosing interval is more limited  In humans, AUC/MIC value >350 was an independent factor associated with clinical success in patients with S.aureus proven lower respiratory tract infection  Tetracyclines
  • 41. DE-ESCALATION THERAPY  Initial administration of broad spectrum empirical treatment  To cover pathogens, most frequently related to the infection  Rapid adjustment of antibacterial treatment once the causative pathogen has been identified
  • 43. DURATION OF ANTIBIOTIC THERAPY  The optimal duration of antibiotic therapy for bacteremia is unknown.  some evidence that would suggest that there is no significant difference in mortality, clinical and microbiological cure b/n shorter and long durations  i.e. 5 – 7 days versus 8 -21 days in critically ill patients with bacteremia.
  • 44. ANTIBACTERIAL CYCLING  The scheduled rotation of one class of antibacterial  One or more different classes with comparable spectra of activity  Different mechanisms of resistance  Some weeks and a few months
  • 45. PRE-EMPTIVE THERAPY  The administration of antimicrobials in certain patients at very high risk of opportunistic infections before the onset of clinical signs of infection  Developed in hematological patients and/or transplant recipients  CMV, aspergillosis  In critical illness patients at high risk of candidemia or invasive candidiasis
  • 46. CANDIDA SCORE  A bedside scoring system for preemptive antifungal treatment in nonneutropenic critically ill patients with Candida colonization. Crit Care Med 2006; 34: 730-7  “Candida score” >2.5 accurately selected patients who would benefit from early antifungal treatment. Candida score = 0.908* (TPN) + 0.997* (surgery)+ 1.112* (multifocal candida colonization) + 2.038* (severe sepsis) 1 if present 0 if absent
  • 47. MULTIDRUG RESISTANT BACTERIA  Increasing prevalence of multidrug-resistant pathogens in ICUs  CDC Report shows from 1999 and 2006/2007  VRE (from 24.7% to 33.3 % of enterococci isolates)  MRSA (from 53.5 % to 56.2 % of S. aureus isolates)  P. aeruginosa resistant to imipenem (from16.4 to 25.3) or fluoroquinolones (from 23.0 to 30.7) from P. aeruginosa isolates
  • 48. RISK FACTORS  Older age  Presence of underlying comorbid conditions  higher severity of illness indices  Long hospital courses prior to the ICU admission,  Receipt of antimicrobial therapy prior to the ICU admission.  Presence of indwelling devices  Recent surgery or other invasive procedure  Frequent manipulation and contact with healthcare person
  • 49. PREVENTION OF RESISTANCE IN THE ICU  Strategies can be separated into two major categories:  strategies that attempt to improve the efficacy and utilization of antimicrobial therapy  infection control measures
  • 50. INFECTION CONTROL MEASURES  good hand hygiene compliance  Active surveillance of patients for asymptomatic colonization  Institution surveillance for infections with multidrug-resistant bacteria  Daily chlorhexidine bathing
  • 51. NOVEL BIOMARKERS  PROCALCITONIN  best studied biomarker for guiding antibiotic treatment duration in the hospital setting.  It’s dynamics within 72 hours after onset of sepsis may be correlated both with appropriateness of the empirical antibiotic therapy  integrated in clinical algorithms have been shown to reduce the duration of antibiotic courses by 25-65% in hospitalized and more severely ill patients with CAP and sepsis
  • 52. REFERENCES  Harrison's Principles of Internal Medicine, 19th ed  Up-to-date 21.6  Practice Guidelines for Evaluating New Fever in Critically Ill Adult Patients. From the National Institutes of Health, Bethesda, and the Johns Hopkins Hospital and St. Agnes Hospital  Annual Update in Intensive Care and Emergency Medicine 2016